Ya-Liang Zhang (Yaliang Zhang)

Years Active: 2019-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Rongjie Cheng, Fanying Li, Maolei Zhang, Xin Xia, Jianzhuang Wu, Xinya Gao, Huangkai Zhou, Zhi Zhang, Nunu Huang, Xuesong Yang, Ya-Liang Zhang, Shunli Shen, Tie-Bang Kang, Ze-Xian Liu, Feizhe Xiao, Hongwei Yao, Jianbo Xu, Chao Yan, Nu Zhang
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers. Cell research (2022)
Tengfei Huang, Tianqi Xu, Yangfan Wang, Yan Zhou, Dandan Yu, Zhiyuan Wang, Linfang He, Zhangpeng Chen, Ya-Liang Zhang, Don Davidson, Yuyuan Dai, Chunhua Hang, Xiangyu Liu, Chao Yan
Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. Autophagy 17 (11) (2021)
Lin-Ying Xia, Rong Yang, Ya-Liang Zhang, Yi-Chun Chu, Ya-Lin Qi, Ruo-Jun Man, Zhong-Chang Wang, Bao-Zhong Wang, Hai-Liang Zhu
Design, synthesis, and biological evaluation of 2,3-diphenyl-cycloalkyl pyrazole derivatives as potential tubulin polymerization inhibitors. Chemical biology & drug design 94 (5) (2019)
Ruo-Jun Man, Ya-Liang Zhang, Ai-Qin Jiang, Hai-Liang Zhu
A patent review of RAF kinase inhibitors (2010-2018). Expert opinion on therapeutic patents 29 (9) (2019)

Ya-Liang Zhang.css-eqlu8i{font-size:small;padding-left:4px;} (Yaliang Zhang)